FDA committee recommends approval for Viagra rival

A committee of specialists at the US Food and Drug Administration (FDA) has recommended that the administration proceed with the approval of a new oral formulation of the drug apomorphine (Uprima) to treat impotence. Doctors predict that it will compete strongly with the highly popular drug sildenafil (Viagra).

Placed under the tongue, the drug encourages erections by stimulating the release of dopamine, which mediates the cerebral role …